Did you know? The Aculabs web portal has both email and SMS notification capabilities for when critical results are posted. Our supplemental critical notifications are fully HIPAA-compliant. Contact our Client Support team for more information on setting up critical notifications!
Last Updated: October 7th 2024
| Analyte Type | Test Code | Analyte | Reference Range | Panic Range |
|---|---|---|---|---|
| TDM | 329 | Carbamazepine (Tegretol) | 4.0 -12 ug/mL | >12.0 |
| TDM | 329 | Carbamazepine (Tegretol) | 4.0 -12 ug/mL | >12.0 |
| TDM | 789 | Valproic acid (Depak) | 50 - 100 ug/mL | >100.0 |
| TDM | 300 | Digoxin | 0.6 - 1.2 ng/mL | >2.0 |
| TDM | 771 | Gentamicin Peak | 5.0 - 10.0 ug/mL | >10.0 |
| TDM | 786 | Gentamicin trough | 0.5 - 2.0 ug/mL | >4.0 |
| TDM | 350 | Levetiracetam (KEPPRA) | 6.0-46 ug/mL | >50.0 |
| TDM | 129 | Lithium | 0.6 - 1.2 mmol/L | >1.5 |
| TDM | 320 | Phenobarbital | 10.0 - 40 ug/mL | >45.0 |
| TDM | 301 | Phenytoin (Dilantin) | 10.0 - 20.0 ug/mL | >25.0 |
| TDM | 3175 | Tacrolimus (Prograf) | 5.0-20.0 ng/mL | <5.0 and >20.0 |
| TDM | 321 | Theophylline | 10.0 - 20.0 ug/mL | >25 |
| TDM | 893 | Vancomycin Peak | 20.0 - 40.0 ug/mL | >40.0 |
| TDM | 894 | Vancomycin Trough | 10.0 - 20.0 ug/mL | >25.0 |
| Thyroid function | 303 | T 3 uptake | 28 % - 41 % | |
| Thyroid function | 3224 | Total T3 | 80-200 ng/dL | |
| Thyroid function | 304 | Thyroxin (T4) | 4.5 - 11.7 ug/dL | |
| Thyroid function | 327 | Thyroid Stimulating Hormone (TSH) | 0.3 - 4.2 uIU/mL | |
| Thyroid function | 703 | Free T3 | 2.0 - 4.4 pg/mL | |
| Thyroid function | 704 | Free T4 | 0.9 - 1.7 ng/dL | |
| Parathyroid Hormone | 712 | Parathyroid Hormone Intact (PTH I) | 15-65 pg/mL | |
| Lipid | 105 | Cholesterol | < 200 mg/dL | |
| Lipid | 193 | Triglycerides | <150 mg/dL | |
| Lipid | 192 | HDL | >40 mg/dL | |
| Tumor Markers | 3109 | AFP | <8.3 ng/mL | >15 |
| Tumor Markers | 328 | Prostate Specific Antigen (PSA) | <4.0 ng/mL | >12.0 |
| Tumor Markers | 332 | Carcinoembryonic Antigen (CEA) | Nonsmoker <3.8 ng/mL Smoker <5.5 ng/mL | >75 |
| Tumor Markers | 680 | Cancer Antigen 125 (CA 125) | <38.1 U/mL | |
| Anemia | 347 | B12 | 232-1245 pg/mL | |
| Anemia | 348 | Folate (Folic Acid) | >4 ng/mL | |
| Anemia | 324 | Ferritin | M 30 - 400 ng/mL F 10 - 200 ng/mL | |
| Chemistry | 107 | Albumin | 3.5 - 5.2 g/dL | |
| Chemistry | 109 | Alkaline Phosphatase (ALP) | 35-129 U/L | >500 |
| Chemistry | 120 | ALT (SGPT) | <40 U/L | |
| Chemistry | 139 | Ammonia | 11-60 umol/L | >150 |
| Chemistry | 143 | Amylase | 28 - 100 U/L | >200 |
| Chemistry | 111 | AST (SGOT) | <40 U/L | >100 |
| Chemistry | 7533 | BNP | <100 pg/mL | >300 |
| Chemistry | 100 | Calcium | 8.4 - 10.2 mg/dL | < 6.5 and >14.0 |
| Chemistry | 118 | Chlorides (Cl) | 98 - 107 mmol/L | < 80 and >125 |
| Chemistry | 138 | CK | M 39 - 308 U/L F 26 - 192 U/L | >400 |
| Chemistry | 145 | CK-MB | < 5.0 ng/mL | >25 |
| Chemistry | 167 | CO2 | 22 - 32 mmol/L | < 15 and >40 |
| Chemistry | 3128 | Cortisol AM | 5-20 µg/dL | |
| Chemistry | 770 | Cortisol PM | 2.5-12 µg/dL | |
| Chemistry | 509 | C-Reactive Protein (hs-CRP) | <1.0 mg/L | |
| Chemistry | 507 | C-Reactive Protein (Inflammatory) | <8.0 mg/L | |
| Chemistry | 101 | Creatinine | 0.6 - 1.5 mg/dL | >5.0 |
| Chemistry | 136 | Direct Bilirubin | <0.3 mg/dL | >3.0 |
| Chemistry | 794 | Follicle Stimulating Hormone (FSH): | *See Test 794* | |
| Chemistry | 794 | Male | 1.5 - 12.4 mIU/mL | |
| Chemistry | 794 | Female, Follicular phase | 3.5 - 12.5 mIU/mL | |
| Chemistry | 794 | Female, Ovulation phase | 4.7 - 21.5 mIU/mL | |
| Chemistry | 794 | Female, Luteal phase | 1.7 - 7.7 mIU/mL | |
| Chemistry | 794 | Female, Postmenopause | 25.8 - 134.8 mIU/mL | |
| Chemistry | 121 | GGT | M 8 - 61 U/L F 5 - 36 U/L | >700 |
| Chemistry | 102 | Glucose | 65 - 99 mg/dL | <40 and >350 |
| Chemistry | 157 | Glucose Post prand | 140 - 200 mg/dL | >450 |
| Chemistry | 124 | Hemoglobin A1c (glyco) | <5.7% | |
| Chemistry | 334 | Human Chorionic Gonadotropin+β (hCG+β) | *See Test 334* | |
| Chemistry | 334 | Male | < 2 mIU/mL | |
| Chemistry | 334 | Nonpregnant premenopausal | <1 mIU/mL | |
| Chemistry | 334 | Postmenopausal women | <7 mIU/mL | |
| Chemistry | 125 | Iron (Fe) | M 59 - 158 ug/dL F 37 - 145 ug/dL | |
| Chemistry | 252 | Lactic Acid | 0.5-2.2 mmol/L | >2.5 |
| Chemistry | 110 | LDH | 135 - 225 U/L | >500 |
| Chemistry | 796 | Luteinizing Hormone (LH) | *See Test 796* | |
| Chemistry | 796 | Male | 1.7 - 8.6 mIU/mL | |
| Chemistry | 796 | Female, Follicular phase | 2.4 - 12.6 mIU/mL | |
| Chemistry | 796 | Female, Ovulation phase | 14.0 - 95.6 mIU/mL | |
| Chemistry | 796 | Female, Luteal phase | 1.0 -11.4 mIU/mL | |
| Chemistry | 796 | Female, Postmenopause | 7.7 - 58.5 mIU/mL | |
| Chemistry | 346 | LIPASE | 13 - 60 U/L | |
| Chemistry | 142 | Magnesium | 1.6 - 2.6 mg/dL | <1.0 and >5.0 |
| Chemistry | 144 | Phosphorus | 2.5 - 4.5 mg/dL | <1.0 and >9.0 |
| Chemistry | 117 | Potassium (K) | 3.4 - 5.3 mmol/L | < 2.8 and >5.8 |
| Chemistry | 4847 | PreAlbumin | 20 - 40 mg/dL | |
| Chemistry | 3444 | ProBNP | <125 pg/mL for <75Y <450 pg/mL for >75Y | >450 for <75Y >900 for >75Y |
| Chemistry | 369 | Procalcitonin | <0.05 ng/mL | >0.5 |
| Chemistry | 3206 | Prolactin | M 4.0 - 15.2 ng/mL F 4.8 - 23.3 ng/mL | |
| Chemistry | 116 | Sodium (Na) | 135 - 145 mmol/L | < 125 and >155 |
| Chemistry | 3244 | Testosterone | M 193 - 827 ng/dL F < 48 ng/dL | |
| Chemistry | 108 | Total Bilirubin | <1.2 mg/dL | >10.0 |
| Chemistry | 106 | Total Protein (TP) | 6.4 - 8.3 g/dL | |
| Chemistry | 776 | Transferrin | 200 - 360 mg/dL | |
| Chemistry | 960 | Troponin I | <45 ng/L | >100 |
| Chemistry | 126 | Unsaturated Iron-Binding Capacity (UIBC) | 112 - 347 ug/dL | |
| Chemistry | 103 | Urea Nitrogen (BUN) | 8 - 23 mg/dL | >80.0 |
| Chemistry | 104 | Uric Acid | M 3.5 - 8.4 mg/dL F 2.2 - 7.3 mg/dL | |
| Chemistry | 3521 | Vitamin D | > 30 ng/mL | |
| Hematology | 200 | White Blood Cells | 3.5-11.0 K/cumm | < 2.5 and >25.0 |
| Hematology | 222 | ABS. Neutrophils | 1.6-6.1 K/cumm | |
| Hematology | 223 | ABS. Lymphocytes | 1.2-3.7 K/cumm | |
| Hematology | 209 | % Neutrophils | 34.0 % - 71.1 % | |
| Hematology | 211 | % Lymphocytes | 19.3 % - 51.7 % | |
| Hematology | 212 | % Monocytes | 4.7 % - 12.5 % | |
| Hematology | 673 | % Eosinophils | 0.0 % - 7.0 % | |
| Hematology | 672 | % Basophils | 0.0 % - 1.2 % | |
| Hematology | 210 | Immature Granulocytes | 0.0 - 0.4% | |
| Hematology | 201 | RBC | M 3.6 - 5.6 M/cu.mm, F 3.3 - 4.9 M/cu.mm | < 2.0 and >7.5 |
| Hematology | 203 | Hematocrit | M 36 - 51 % F 32 - 46 % | <22.0% and >55% |
| Hematology | 202 | Hemoglobin | M 12.1 - 17.1 g/dL F 10.7 - 15.1 g/dL | <7.0 and >18.0 |
| Hematology | 204 | MCV | 81 - 100 fL | |
| Hematology | 205 | MCH | 25 - 32 pg | |
| Hematology | 206 | MCHC | 31 - 36 g/dL | |
| Hematology | 207 | RDW | 11.6 - 14.4 Percent | |
| Hematology | 208 | Platelets | 126 - 400 K/cumm | <40 and >800 |
| Hematology | 213 | MPV | 9.4 - 12.4 fL | |
| Hematology | 622 | Immature Platelets Fraction | 1.2%-8.7% | |
| Hematology | 219 | Retic Count | 0.2% - 2.5% | |
| Hematology | 624 | Immature Retic Fraction | M 2.3 - 13.4 % F 3.0 - 15.9 % | |
| Hematology | 296 | RET-He | 28.2 - 36.6 | |
| Hematology | 600 | Sedimentation Rate | M: <15 mm/h for <50Y <20 mm/h for >50Y F: <20 mm/h for <50Y <30 mm/h for >50Y | |
| Hematology | 619 | D-Dimer HS 500 | <500 ng/mL FEU | |
| Hematology | 601 | Prothrombin time | 10.1-12.5 | < 9.0 and >44.8 |
| Hematology | 608 | INR | 0.8 - 1.1 | < 0.8 and >4.0 |
| Hematology | 604 | PTT | 25.1 - 36.5 sec | <18 sec and >55 |
| Infectious diseases | 721C | HIV Combo | Nonreactive | |
| Infectious diseases | 500 | RPR | Nonreactive | |
| Infectious diseases | 501 | Treponema Antibodies | Negative | |
| Infectious diseases | HATA | Hepatitis A, Total Abs | Nonreactive | Reactive |
| Infectious diseases | 736 | Hepatitis A, IgM | Nonreactive | Reactive |
| Infectious diseases | 732 | Hepatitis B Surface Antigen | Nonreactive | |
| Infectious diseases | 710 | Hepatitis B Surface Antibody | Nonreactive | |
| Infectious diseases | 2448 | Hepatitis B Surface Antibody, Quant | <8.5mIU/mL | |
| Infectious diseases | 735 | Hepatitis B Core Total Antibody | Nonreactive | Reactive |
| Infectious diseases | 2457 | Hepatitis B Core IgM | Nonreactive | Reactive |
| Infectious diseases | 739 | Hepatitis C Antibodies | Nonreactive | Reactive |
| Infectious diseases | 610Q | QuantiFERON®-TB Gold Plus | Negative | |
| Immunology/Serology | 504 | RA | Negative | |
| Urine | 4001 | Color | Yellow | |
| Urine | 4002 | Clarity | Clear | |
| Urine | 400 | Glucose | Negative | |
| Urine | 401 | Bilirubin | Negative | |
| Urine | 402 | Ketone | Negative | |
| Urine | 403 | Spec. Gravity | <1.030 | |
| Urine | 404 | Blood | Negative | |
| Urine | 405 | PH | 5.0-8.0 | |
| Urine | 406 | Protein | Negative | |
| Urine | 408 | Nitrites | Negative | |
| Urine | 409 | Leukocyte | Negative | |
| Urine | 168 | Sodium, Urine/Random | No ref. range est. | |
| Urine | 430 | Sodium, Urine/24 HR | 40-220 mmol/24 hr | |
| Urine | 170 | Chloride, Urine/Random | No ref. range est. | |
| Urine | 428 | Chloride, Urine/24 HR | 110-250 mmol/24 hr | |
| Urine | 169 | Potassium, Urine/Random | No ref. range est. | |
| Urine | 427 | Potassium, Urine/24 HR | 25-125 mmol/24hr | |
| Urine | 423 | Creatinine, Urine/Random | No ref. range est. | |
| Urine | 424 | Creatinine, Urine/24 HR | M 1.0 - 2.3 g/24hr, F 0.4- 1.6 g/24hr | |
| Urine | 420 | Urine volume/24 HR | 800-2000 mL/24hr | |
| Urine | 450 | Creatinine Clearance | 71-151 mL/min | |
| Urine | 425 | Total Protein, Urine/24 HR | <150 mg/24hr | |
| Urine | 406Q | Total Protein, Urine/Random | No ref. range est. | |
| Urine | 4555 | Microalbumin, Urine/24 HR | <30 mg/24hr | |
| Urine | 6517 | Microalbumin,Urine/Random | No ref. range est. | |
| Drug Screen | Amphetamine | Negative | ||
| Drug Screen | Barbiturates | Negative | ||
| Drug Screen | Benzodiazepines | Negative | ||
| Drug Screen | Cannabinoids (THC) | Negative | ||
| Drug Screen | Cocaine metabolites | Negative | ||
| Drug Screen | ETOH | Negative | ||
| Drug Screen | Opiate | Negative | ||
| Drug Screen | Phencyclidine (PCP) | Negative | ||
| Microbiology | Microorganism in the blood | Negative | Positive | |
| Microbiology | Clinical Significant microorganism from a sterile body site | Negative | Positive | |
| Microbiology | Group A strep from steril body fluid | Negative | Positive | |
| Microbiology | Initial stool isolates of Salmonella, Shegella and Campylobacter, Clostridium Difficile | Negative | Positive | |
| Microbiology | Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis | Negative | ||
| Microbiology | Respiratory Viruses: Influenza A&B, RSV, SARS-CoV-2 | Negative | Positive | |
| Microbiology | Enteric Viral Panel: norovirus, rotavirus, adenovirus, human astrovirus, and sapovirus | Negative | Positive | |
| Microbiology | Enteric Bacterial Panel: Salmonella spp., Shigella spp./enteroinvasive Escherichia coli (EIEC), Campylobacter spp. (jejuni and coli), Shiga toxin producing organisms (STEC, Shigella dysenteriae) | Negative | Positive | |
| Microbiology | Other microbiology critical values: Methicillin Resistant Staphylococcus Aureus(MRSA), Vancomycin Resistant Enterococcus (VRE), Multi-drug Resistant organism (MDR) and Extended-Spectrum Beta Lactamase (ESBL), CRE, CRAB | Negative | Positive |